Does METHYLPREDNISOLONE Cause Focal segmental glomerulosclerosis? 81 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 81 reports of Focal segmental glomerulosclerosis have been filed in association with METHYLPREDNISOLONE (Medroloan II SUIK). This represents 0.1% of all adverse event reports for METHYLPREDNISOLONE.
81
Reports of Focal segmental glomerulosclerosis with METHYLPREDNISOLONE
0.1%
of all METHYLPREDNISOLONE reports
2
Deaths
50
Hospitalizations
How Dangerous Is Focal segmental glomerulosclerosis From METHYLPREDNISOLONE?
Of the 81 reports, 2 (2.5%) resulted in death, 50 (61.7%) required hospitalization, and 5 (6.2%) were considered life-threatening.
Is Focal segmental glomerulosclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METHYLPREDNISOLONE. However, 81 reports have been filed with the FAERS database.
What Other Side Effects Does METHYLPREDNISOLONE Cause?
Off label use (10,364)
Drug ineffective (9,959)
Product use in unapproved indication (4,115)
Condition aggravated (3,784)
Headache (3,419)
Fatigue (3,250)
Pyrexia (3,226)
Pain (3,165)
Nausea (3,105)
Pneumonia (3,006)
What Other Drugs Cause Focal segmental glomerulosclerosis?
TACROLIMUS (339)
MYCOPHENOLATE MOFETIL (181)
PREDNISONE (173)
CYCLOSPORINE (96)
PREDNISOLONE (73)
RITUXIMAB (73)
BASILIXIMAB (67)
OMEPRAZOLE (60)
LANSOPRAZOLE (55)
MYCOPHENOLIC ACID (55)
Which METHYLPREDNISOLONE Alternatives Have Lower Focal segmental glomerulosclerosis Risk?
METHYLPREDNISOLONE vs METHYLPREDNISOLONE ACEPONATE
METHYLPREDNISOLONE vs METHYLPREDNISOLONE HEMISUCCINATE
METHYLPREDNISOLONE vs METILDIGOXIN
METHYLPREDNISOLONE vs METOCLOPRAMIDE
METHYLPREDNISOLONE vs METOLAZONE